Preparation and Immunological Efficacy Evaluation of mRNA Vaccines Targeting the Spike Protein of Bovine Coronavirus
Vaccines · 12.11.2025 · 13 (11) · 1155
DOI: 10.3390/vaccines13111155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 12.11.2025. Verfasst von Shuyue Liu und 16 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Xinjiang Agricultural University, Urumqi 830052, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Bovine coronaviruses (BCoV) are endemic worldwide, causing diarrhea, winter dysentery, and bovine respiratory disease in newborn calves. These lead to higher calf mortality, reduced growth of fattening cows, and lower milk production in adult cows, resulting in significant losses to the cattle industry. Since commercial preventive drugs are not available in China, and existing treatments can only reduce the mortality of sick calves without fundamental control, the development of safe and effective vaccines is crucial.
Methods
Two mRNA vaccines targeting the BCoV spiny receptor-binding domain (S-RBD) were prepared: XBS01 and XBS02. These two mRNAs, optimized for coding by AI and encapsulated in lipid nanoparticles (LNPs), were injected intramuscularly into mice (10 μg per mouse, twice, 2 weeks apart); a blank control group was not immunized. Serum antibodies, memory B/T cell activation and cytokine secretion were assessed by ELISA, flow cytometry and ELISpot.
Results
Both vaccines induced humoral and cellular immunity:anti-S-RBD IgG titers were higher than those of the control group, and there was memory B-cell production and T-cell activation. XBS02 was superior to XBS01 in terms of peak antibody, memory B-cell frequency, T-cell activation rate, and IFN-γ/IL-2 secretion, and showed a stronger Th 1 response.
Conclusions
Both BCoV S-RBD mRNA vaccines had good immunogenicity, with XBS02 providing better protection. This study supports the optimization and application of BCoV mRNA vaccines and accumulates data for mRNA technology in veterinary practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Veterinary Medicine, Xinjiang Agricultural University, Urumqi 830052, China.
- Veterinary Rasearch Institute Xinjiang Uygur Autonomous Region Academy of Animal Husbandry Sciences (Xinjiang Uygur Autonomous Region Academy of Animal Husbandry Sciences Center for Clinical Veterinary Medicine), Urumqi…
- Xinjiang Animal Disease Control and Prevention Engineering Technology Research Center, Urumqi 830000, China.
- College of Animal Science and Technology, Shihezi University, Shihezi 832003, China.
- College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.
- Vaccine Center, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
ORCID-Profile: Shuyue Liu, Ang Lin
Zitieren
APA
Liu, S., Gong, Z., Wang, P., Chen, F., Fu, X., Fan, H., Li, Y., Han, X., Chen, J., Zhang, L., Xue, L., Bai, H., Liu, S., Huang, L., Du, W., Lin, A., & Xia, J. (2025). Preparation and Immunological Efficacy Evaluation of mRNA Vaccines Targeting the Spike Protein of Bovine Coronavirus. Vaccines, 13(11), 1155. https://doi.org/10.3390/vaccines13111155
Vancouver
Liu S, Gong Z, Wang P, Chen F, Fu X, Fan H, et al. Preparation and Immunological Efficacy Evaluation of mRNA Vaccines Targeting the Spike Protein of Bovine Coronavirus. Vaccines. 2025;13(11):1155. doi:10.3390/vaccines13111155
BibTeX
@article{Liu2025,
author = {Liu, Shuyue and Gong, Zhen and Wang, Ping and Chen, Fu and Fu, Xiulong and Fan, Haoyu and Li, Yue and Han, Xiangshu and Chen, Junli and Zhang, Lixue and Xue, Lijun and Bai, Hangfei and Liu, Shufan and Huang, Lulu and Du, Wei and Lin, Ang and Xia, Jun},
title = {Preparation and Immunological Efficacy Evaluation of mRNA Vaccines Targeting the Spike Protein of Bovine Coronavirus},
journal = {Vaccines},
year = {2025},
volume = {13},
number = {11},
pages = {1155},
doi = {10.3390/vaccines13111155}
}
EUVIMED